Tizanidine Tablet
Product Images NDC 70518-3112

5 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 70518-3112). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Tizanidine hydrochloride, the active ingredient shown in the image, illustrating the molecular arrangement including a chloro-substituted aromatic ring and imidazoline moiety.*
FDA Label Image

Fig1 (Fig1)

Fig1 (Fig1)
A line graph showing plasma Tizanidine concentration (ng/mL) over 24 hours post-dosing. It compares four conditions: 2 x 4 mg Tizanidine tablets with food, tablets without food, capsules with food, and capsules without food, illustrating differences in drug concentration over time depending on dosage form and food intake.*
FDA Label Image

Fig2 (Fig2)

Fig2 (Fig2)
A line graph showing improvement in Ashworth Score over time (hours post-dose) for three groups: 16 mg tizanidine, 8 mg tizanidine, and placebo. The vertical axis shows improvement in Ashworth Score, while the horizontal axis shows hours post-dose from 0 to 6. Data points include error bars indicating variability for each group.*
FDA Label Image

Fig3 (Fig3)

Fig3 (Fig3)
A line graph depicting improvement in Ashworth Score over different study time points (End of Titration, End of Maintenance, Endpoint). The graph compares tizanidine (mean dose 28.8 mg) and placebo groups, showing changes in Ashworth Score with error bars for variability at each time point.*
FDA Label Image

Mm1 (Tizanidine 2mg 70518 3112 00)

Mm1 (Tizanidine 2mg 70518 3112 00)
Label for Tizanidine 2 mg tablets, oral dosage form, repackaged by RemedyRepack Inc. The label indicates a quantity of 60 tablets with NDC number 70518-3112-00. The label includes storage instructions, manufacturer information (Dr. Reddy's, Shreveport, LA), and warnings that these tablets are not interchangeable with Tizanidine capsules. The package displays the logo of RemedyRepack and notes that the tablets are white, oval, and marked 'R 179.'*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.